I have the great pleasure of announcing the launch of *Dermatopathology,* a new journal in the field of cutaneous pathology and the official journal of the European Society of Dermatopathology (ESDP).

The ESDP was first founded in Zurich in 1996, initially with no official character. The presidents of the Society were Helmut Kerl, Rino Cerio and Bernard Cribier until my takeover in 2011. The official foundation of the Society is currently taking place in Geneva. The aims and objectives of the ESDP are to educate by organizing meetings, creating slide sets and providing opportunities for trainees in pathology and dermatology to spend time in centers of dermatopathology of their choices; to enhance the co-operation between pathologists and dermatologists interested in dermatopathology; to create a stronger link between dermatopathology and investigative dermatology; to standardize quality criteria of performance in dermatopathology, and to establish a European Diploma of Dermatopathology, which is the equivalent of the Board Examination in the United States, accessible to both pathologists and dermatologists.

For over a century, it has been well accepted that in the specialty of dermatology, most major texts and journals have originated primarily from clinical dermatology. In recent years, many dermatologists and pathologists with extensive expertise in dermatopathology have been recognized. This new journal is an example of this integration. The majority of dermatopathological organizations have a similar proud tradition, and the ESDP is no exception. Like the International Society of Dermatopathology (ISDP) and the American Society of Dermatopathology (ASDP) having respectively the *American Journal of Dermatopathology* and the *Journal of Cutaneous Pathology* as their official journal, the ESDP has now its official journal: *Dermatopathology*.

It is well known that the dermatology and pathology specialties, but especially our patients with skin diseases, profit practically and academically from the recognition and importance of dermatopathology. The foundation of the ESDP undoubtedly paved the way for the first move to develop this medical subspecialty and raise the standards in dermatopathology outside the United States. Moreover, with support from the European Union of Medical Specialists (UEMS) and the ISDP, the ESDP and its founder members are still involved in the International Committee of Dermatopathology (ICDP) Executive Board for training examination and certification.

*Dermatopathology* is a peer-reviewed online-only journal which publishes original scientific articles on diagnostic and experimental dermatopathology. Case reports, clinico-pathologic correlations, controversial issues and studies based on current molecular technologies are welcome. The aim of the journal is to share interesting and most recent clinico-pathologic information with the community of dermatopathology all over the world and to create a stronger link between dermatopathology, clinical dermatology and investigative dermatology. *Dermatopathology* also provides a resource for continuing medical education in cutaneous pathology. Articles will be published online very quickly after acceptance, and therefore be present in PubMed, ensuring the rapid availability of scientific knowledge for all clinicians and researchers interested in this subspecialty. According to the open access principle, the contents of the journal can be retrieved at all times with no charge. I believe that this new journal will be a good complement to the other existing journals in the field and will help to increase the quality of dermatopathology. I invite all the members of the ESDP and all dermatologists and pathologists interested in dermatopathology to submit original articles to *Dermatopathology*. The submission will be free of charge during the first year (4 issues).

I would like to thank all the Editorial Board members and the Associate Editors for their kindness to accept to be with me in this novel experience. As you can see, the members of the editorial team of this journal are, among others, the leading names of the European and American dermatopathology. I am sure that their precious contribution will make this journal one of the best journals in the field. I would also like to thank the Karger team who helped me realize this project.

*Non quia difficilia sunt non audemus, sed quia non audemus, difficilia sunt.*[1](#FN001){ref-type="fn"}

Now it is time to pick up the pen!

*Gürkan Kaya*, MD, PhD, Geneva, Switzerland

Editor-in-Chief

'It is not because things are difficult that we do not dare, but because we do not dare, things are difficult' (Seneca, Letter to Lucilius, letter 104, section 26, line 5).
